Taking a GLP-1 Medication? Here's Tips to Holiday Eating
GLP-1 medications, which include Ozempic, Wegovy, Mounjaro and Zepbound, curb appetite and slow the digestion of food, so ...
More than half of US adults could benefit from GLP-1 medications, researchers find
In a new analysis of national data, researchers at the Richard A. and Susan F. Smith Center for Outcomes Research at Beth ...
Healthcare Dive22h
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
In 2024, coverage for obesity drugs increased to 44% among employers with 500 or more workers, compared to 41% last year, the ...
Eli Lilly: Steep Pullback, Still Compelling Here
LLY's recent sell-off presents a buying opportunity for savvy investors, with strong growth potential in the GLP-1 market ...
Even with access to blockbuster obesity drugs, some people don’t lose weight
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle ...
Anti-obesity drugs increase food waste in some users
Taking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, a new study has found.
emjreviews.com12h
Semaglutide Tops USA Drug Sales Amidst Rising Eligibility and Cost Concerns
In 2023, semaglutide emerged as the top-selling drug in the USA, generating $13.8 billion in sales. Read more.
Jim Cramer on Eli Lilly and Company (LLY): ‘It’s Valuable’
We recently compiled a list of the Jim Cramer on Nvidia Plus Other Stocks. In this article, we are going to take a look at ...
The New York Times21h
New York Times - Top Stories
Trump Names Scott Bessent as His Pick for Treasury Secretary The billionaire hedge fund manager would be responsible for steering President-elect Trump’s unconventional economic agenda. Mr ...